Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06450405 · ClinicalTrials.gov registry record · Phase 4
Androgen Effects on the Reproductive Neuroendocrine Axis
A Phase 4 study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT06450405 is a Phase 4 study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 2 participants.
The verdict
NCT06450405, a Phase 4 study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
This research study investigates whether male-level exogenous androgens inhibit the reproductive neuroendocrine axis in otherwise healthy (non-PCOS) females.
Interventions
- DRUG Testosterone Cypionate 50 MG/ML Injectable Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2025-02-26 |
| Est. Completion | 2025-03-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06450405
The ClinicalTrials.gov registry entry for NCT06450405 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Testosterone Cypionate 50 MG/ML Injectable Solution is the first listed.
NCT06450405 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06450405 about?
NCT06450405 is a clinical study titled "Androgen Effects on the Reproductive Neuroendocrine Axis". This research study investigates whether male-level exogenous androgens inhibit the reproductive neuroendocrine axis in otherwise healthy (non-PCOS) females.
What is the current status of trial NCT06450405?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2025-02-26. Estimated completion is 2025-03-03.
What interventions are being tested in trial NCT06450405?
The interventions under investigation include: Testosterone Cypionate 50 MG/ML Injectable Solution (DRUG).
Who is sponsoring clinical trial NCT06450405?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.